Global Caprolactam (Cas 105-60-2) Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

Caprolactam, a white solid or a colourless liquid, is a lactam or a cyclic amide of caproic acid. Caprolactam is the precursor to Nylon 6, a widely used synthetic polymer. The Caprolactam (Cas 105-60-2) market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global Caprolactam (Cas 105-60-2) market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the Caprolactam (Cas 105-60-2) Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in Caprolactam (Cas 105-60-2) market are: UBE Grupa Azoty Fujian Tianchen Sinopec KuibyshevAzot Hengyi Sumitomo Chemical Alpek Capro DOMO Chemicals Grodno Khimvolokno Lanxess Fibrant CPDC BASF GSFC Hongye Group AdvanSix Luxi Chemical Shandong Haili Chemical Most important types of Caprolactam (Cas 105-60-2) products covered in this report are: Solid Caprolactam Liquid Caprolactam Most widely used downstream fields of Caprolactam (Cas 105-60-2) market covered in this report are: Nylon 6 Resin Nylon 6 Fiber Others Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.